A novel, automated, quantification of abnormal lung parenchyma in patients with COVID-19 infection: Initial description of feasibility and association with clinical outcome.

Date publication

novembre 2020

Journal

Anaesthesia, critical care & pain medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MEYER Nicolas , Pr SOLER Luc , Pr OHANA Mickaël

Tous les auteurs :
Noll E, Soler L, Ohana M, Ludes PO, Pottecher J, Bennett-Guerrero E, Veillon F, Goichot B, Schneider F, Meyer N, Diemunsch P

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33197638

Résumé

Ground-glass opacities are the most frequent radiologic features of COVID-19 patients. We aimed to determine the feasibility of automated lung volume measurements, including ground-glass volumes, on the CT of suspected COVID-19 patients. Our goal was to create an automated and quantitative measure of ground-glass opacities from lung CT images that could be used clinically for diagnosis, triage and research.

Mots clés

ARDS, COVID-19, CT-scan, Infectious disease, Severity assessment, Triage

Référence

Anaesth Crit Care Pain Med. 2020 Nov 13;: